Therapeutic potential of melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity

Bibliography

• FLEGAL KM, CARROLL MD, CL, JOHNSON CL: Prevalence and trends in obesity among US adults, 1999-2000. JAMA (2002) 288(14):1723–1727.
   PubMed Web of Science ®Google Scholar
• MOKDAD AH, FORD ES, BA et al: Prevalence of obesity,, and obesity-related health risk factors, 2001. JAMA (2003) 289(1):76–79.
   PubMed Web of Science ®Google Scholar
• US DEPARTMENT OF HEALTH AND HUMAN SERVICES: The Surgeon Ceneral.'s Call to Action to Prevent and Decrease Overweight and Obesity 2004 Public Health Service. Office of the Surgeon General, Rockville, MD, USA (2001).
   Google Scholar
• KOPELMAN, PG: Obesity as a medical problem. Nature (2000) 404(6778):635–643.
   PubMed Web of Science ®Google Scholar
• MUST A, SPADANO J, COAKLEY EH, FIELD AE, COLDITZ G, DIETZ WH: The disease burden associated with overweight and obesity. JAMA (1999) 282(16):1523–1529.
   PubMed Web of Science ®Google Scholar
• FORD ES, GILES WH, DIETZ WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA (2002) 287(3):356–359.
   PubMed Web of Science ®Google Scholar
• HAFFNER SM, VALDEZ RA, HAZUDA HP, MITCHELL BD, MORALES PA, STERN MP: Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes (1992) 41(6):715–722.
   PubMed Web of Science ®Google Scholar
• ISOMAA B, ALMGREN P, TUOMI T et al.: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care (2001) 24(4):683–689.
   PubMed Web of Science ®Google Scholar
• EXPERT PANEL ON DETECTION, EVALUATION, AND TREATMENT OF HIGH BLOOD CHOLESTEROL IN ADULTS: Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA (2001) 285(19)2486–2497.
   Google Scholar
• WILSON PW, KANNEL WB, SILBERSHATZ H, D'AGOSTINO RB: Clustering of metabolic factors and heart disease. Arch. Intern. Med. (1999) 159(10):1104–1109.
   PubMed Web of Science ®Google Scholar
• TUOMILEHTO J, LINDSTROM J, ERIKSSON JG et al.: Prevention of Type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl.' Med. (2001) 344(18):1343–1350.
   PubMed Web of Science ®Google Scholar
• BAKER BI: Melanin-concentrating hormone: a general vertebrate neuropeptide. Int. Rev Cytol. (1991) 126:1–47.
   PubMed Web of Science ®Google Scholar
• KAWAUCHI H, KAWAZOE I, TSUBOKAWA M, KISHIDA M, BI: Characterization of melanin-concentrating hormone in chum salmon pituitaries. Nature (1983) 305(5932):321–323.
   PubMed Web of Science ®Google Scholar
• PRESSE F, NAHON JL, FISCHER WH, VALE W: Structure of the human melanin concentrating hormone mRNA. Endocrinol (1990) 4(4):632–637.
   Web of Science ®Google Scholar
• VAUGHAN JM, FISCHER WH, HOEGER C, RIVIER J, VALE W: Characterization of melanin-concentrating hormone from rat hypothalamus. Endocrinology (1989) 125(3):1660–1665.
   PubMed Web of Science ®Google Scholar
• NAHON JL, PRESSE F, JC, SAWCHENKO PE, VALE W: The rat melanin-concentrating hormone messenger ribonucleic acid encodes multiple putative neuropeptides coexpressed in the dorsolateral hypothalamus. Endocrinology (1989) 125(4):2056–2065.
   PubMed Web of Science ®Google Scholar
• VIALE A, ZHIXING Y, BRETON C et al: The melanin-concentrating hormone gene in human: flanking region analysis, fine chromosome mapping, and tissue-specific expression. Brain Res. Ma Brain Res. (1997) 46(1-2):243–255.
   PubMedGoogle Scholar
• BITTENCOURTJC, PRESSE F, ARIAS C et al.: The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. Comp. Neurol (1992) 319(2):218–245.
   PubMed Web of Science ®Google Scholar
• ELIAS CF, LEE CE, KELLY JF et al: Characterization of CART neurons in the rat and human hypothalamus. Comp. Neurol (2001) 432(1):1–19.
   PubMed Web of Science ®Google Scholar
• VRANG N, LARSEN PJ, CLAUSEN JT, KRISTENSEN P: Neurochemical characterization of hypothalamic cocaine-amphetamine-regulated transcript neurons. (Online) (1999) 19(10):RC5.
   Google Scholar
• BROBERGER C: Hypothalamic cocaine-and amphetamine-regulated transcript (CART) neurons: histochemical relationship to thyrotropin-releasing hormone, melanin-concentrating hormone, orexin/hypocretin and neuropeptide Y. Brain Res. (1999) 848(1-2):101–113.
   PubMed Web of Science ®Google Scholar
• CHAMBERS J, AMES RS, BERGSMA Det al.: Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1. Nature (1999) 400(6741):261–265.
   Google Scholar
• •This study, as well as that of [24], was one of the first reports to describe the MCH–1R.
   Google Scholar
• LEMBO PM, GRAZZINI E, CAO J et al:The receptor for the orexigenic peptide melanin-concentrating hormone is a G-protein-coupled receptor. Nat. Cell Biol. (1999) 1(5):267–271.
   PubMed Web of Science ®Google Scholar
• SAITO Y, NOTHACKER HP, WANG Z, LIN SH, LESLIE F, CIVELLI 0: Molecular characterization of the melanin-concentrating-hormone receptor. Nature (1999) 400(6741):265–269.
   PubMed Web of Science ®Google Scholar
• •This study, as well as that of [22], was one of the first reports to describe the MCH–1R.
   Google Scholar
• BACHNER D, KREIENKAMP H, WEISE C, BUCK F, RICHTER D: Identification of melanin concentrating hormone (MCH) as the natural ligand for the orphan somatostatin-like receptor 1 (SLC-1). FEBS Lett. (1999) 457(3):522–524.
   PubMed Web of Science ®Google Scholar
• SHIMOMURA Y, MORI M, SUGO T et al.: Isolation and identification of melanin-concentrating hormone as the endogenous ligand of the SLC-1 receptor. Biochem. Biophys. Res. Commun. (1999) 261(3):622–626.
   PubMed Web of Science ®Google Scholar
• HAWES BE, KIL E, GREEN B,'NEILL K, FRIED S, GRAZIANO MP: The melanin-concentrating hormone receptor couples to multiple G proteins to activate diverse intracellular signaling pathways. Endocrinology (2000) 141(12):4524–4532.
   PubMed Web of Science ®Google Scholar
• TAN CP, SANO H, IWAASA H et al: Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific gene expression. Cenomics (2002) 79(6):785–792.
   Google Scholar
• •This paper describes the species-specific expression of MCH-2R, emphasising the importance of the animal models used for drug development.
   Google Scholar
• SAITO Y, CHENG M, LESLIE FM, 0: Expression of the melanin-concentrating hormone (MCH) receptor in the rat brain. I Comp. Nemo]. (2001) 435(1):26–40.
   Google Scholar
• WANG S, BEHAN J, O'NEILL K et al.: Identification and pharmacological characterization of a novel human melanin-concentrating hormone receptor, MCH-R2. Biol Chem. (2001) 276(37):34664–34670.
   Google Scholar
• AN S, CUTLER G, ZHAO JJ et al: Identification and characterization of a melanin-concentrating hormone receptor. Proc. Natl. Acad. Sci. USA (2001) 98(13):7576–7581.
   PubMed Web of Science ®Google Scholar
• SAILER AW, SANO H, ZENG Z et al.: Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R. Proc. Natl. Acad. Sci. USA (2001) 98(13):7564–7569.
   PubMed Web of Science ®Google Scholar
• RODRIGUEZ M, BEAUVERGER P, NAIME I et al.: Cloning and molecular characterization of the novel human melanin-concentrating hormone receptor MCH2. Mol. Pharmacol (2001) 60(4):632–639.
   PubMed Web of Science ®Google Scholar
• MORI M, HARADA M, TERAO Y et al: Cloning of a novel G protein-coupled receptor, SLT, a subtype of the melanin-concentrating hormone receptor. Biochem. Biophys. Res. Commun. (2001) 283(5):1013–1018.
   PubMed Web of Science ®Google Scholar
• HILL J, DUCKWORTH M, P et al.: Molecular cloning and functional characterization of MCH2, a novel human MCH receptor. J. Biol. Chem. (2001) 276(23):20125–20129.
   PubMed Web of Science ®Google Scholar
• FRIED S, O'NEILL K, HAWES BE: Cloning and characterization of rhesus monkey MCH-R1 and MCH-R2. Peptides (2002) 23(8):1401–1408.
   PubMed Web of Science ®Google Scholar
• CHIOCCHIO SR, GALLARDO MG, LOUZAN P, GUTNISKY V, TRAMEZZANI JH: Melanin-concentrating hormone stimulates the release of luteinizing hormone-releasing hormone and gonadotropins in the female rat acting at both median eminence and pituitary levels. Biol. Reprod. (2001) 64(5):1466–1472.
   PubMed Web of Science ®Google Scholar
• TSUKAMURA H, THOMPSON RC, TSUKAHARA S et al.: Intracerebroventricular administration of melanin-concentrating hormone suppresses pulsatile luteinizing hormone release in the female rat. Neuroendocrinol (2000) 12(6):529–534.
   Web of Science ®Google Scholar
• MURRAY JF, ADAN RA, WALKER R et al.: Melanin-concentrating hormone, receptors and regulation of luteinizing hormone release. Neuroendocrinol (2000) 12(3):217–223.
   Web of Science ®Google Scholar
• GONZALEZ MI, BAKER BI, WILSON CA: Stimulatory effect of melanin-concentrating hormone on luteinising hormone release. Neuivendocrinology (1997) 66(4):254–262.
   PubMed Web of Science ®Google Scholar
• KENNEDY AR, TODD JF, DHILLO WS et al.: Effect of direct injection of melanin-concentrating hormone into the paraventricular nucleus: further evidence for a stimulatory role in the adrenal axis via SLC-1. Neuroendocrinol (2003) 15(3):268–272.
   Web of Science ®Google Scholar
• BLUET-PAJOT MT, PRESSE F, VOKO Z et al.: Neuropeptide-E-I antagonizes the action of melanin-concentrating hormone on stress-induced release of adrenocorticotropin in the rat. (1995) 7(4):297–303.
   Google Scholar
• JEZOVA D, BARTANUSZ V, WESTERGREN I et al.: Rat melanin-concentrating hormone stimulates adrenocorticotropin secretion: evidence for a site of action in brain regions protected by the blood-brain barrier. Endocrinology (1992) 130(2):1024–1029.
   PubMed Web of Science ®Google Scholar
• KELA J, SALMI P,-GIORGINI R, HEILIG M, WAHLESTEDT C: Behavioural analysis of melanin-concentrating hormone in rats: evidence for orexigenic and anxiolytic properties. Regal. Pept. (2003) 114(2-3):109–114.
   PubMed Web of Science ®Google Scholar
• MONZON ME, DE BARIOGLIO SR: Response to novelty after i.c.v. injection of melanin-concentrating hormone (MCH) in rats. Physiol Behav. (1999) 67(5):813–817.
   Google Scholar
• ELIAS CE SAPER CB,-FLIER E et al.: Chemically defined projections finking the mediobasal hypothalamus and the lateral hypothalamic area. J. Comp. Nemo]. (1998) 402(4):442–459.
   Google Scholar
• HANADA R, NAKAZATO M, MATSUKURA S, MURAKAMI N, YOSHIMATSU H, SAKATA T: Differential regulation of melanin-concentrating hormone and orexin genes in the agouti-related protein/melanocortin-4 receptor system. Biochem. Biophys. Res. Commun. (2000) 268(1):88–91.
   PubMed Web of Science ®Google Scholar
• QU D, LUDWIG DS, GAMMELTOFT S et al.: A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature (1996) 380(6571):243–247. is the first study to provide convincing evidence for a role of MCH in the regulation of food intake and energy homeostasis.
   Google Scholar
• DELLA-ZUANA 0, PRESSE F, C, DUHAULT J, NAHON JL, LEVENS N: Acute and chronic administration of melanin-concentrating hormone enhances food intake and body weight in Wistar and Sprague-Dawley rats. Int. .1. Obes. Relat. Metab. Disord. (2002) 26(10):1289–1295.
   Google Scholar
• ROSSI M, CHOI SJ, O'SHEA D, MIYOSHI T, GHATEI MA, BLOOM SR: Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology (1997) 138(1):351–355.
   PubMed Web of Science ®Google Scholar
• LUDWIG DS, MOUNTJOY KG, TATRO JB et al.: Melanin-concentrating hormone: a functional melanocortin antagonist in the hypothalamus. Am. J. Physiol (1998) 274(4 Pt 1):E627–633.
   Google Scholar
• TRITOS NA, VICENT D, GILLETTE J, LUDWIG DS, FLIER ES, MARATOS-FLIER E: Functional interactions between melanin-concentrating hormone, neuropeptide Y, and anorectic neuropeptides in the rat hypothalamus. Diabetes (1998) 47(11):1687–1692.
   PubMed Web of Science ®Google Scholar
• STRICKER-KRONGRAD A, DIMITROV T, BECK B: Central and peripheral dysregulation of melanin-concentrating hormone in obese Zucker rats. Brain Res. Ma Brad] Res. (2001) 92(1-2):43–48.
   PubMedGoogle Scholar
• SERGEYEV V, BROBERGER C, GORBATYUK 0, HOKFELT T: Effect of 2-mercaptoacetate and 2-deoxy-D-glucose administration on the expression of NPY, AGRP, POMC, MCH and hypocretin/ orexin in the rat hypothalamus. Neuroreport (2000) 11(1):117–121.
   PubMed Web of Science ®Google Scholar
• ITO M, GOMORI A, ISHIHARA A et al: Characterization of MCH-mediated obesity in mice. Am. I Physiol Endocrinol. Metab. (2003) 284(5):E940–945.
   Google Scholar
• GOMORI A, ISHIHARA A, ITO M et al.: Chronic intracerebroventricular infusion of MCH causes obesity in mice. Am. I Physiol. Endocrinol. Metab. (2003) 284(3):E583–E588.
   Google Scholar
• SHEARMAN LP, CAMACHO RE, STRIBLING DS et al: Chronic MCH-1 receptor modulation alters appetite, body weight and adiposity in rats. Eui: Pharmacol (2003) 475(1–3):37–47. 1121
   Google Scholar
• LUDWIG DS, TRITOS NA, MASTAITIS JW et al.: Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance.' Clin. Invest. (2001) 107(3):379–386.
   Google Scholar
• •This study uses genetically modified mice to confirm and extend pharmacological evidence demonstrating that chronic central MCH signaling promotes obesity and insulin resistance in mice.
   Google Scholar
• SHIMADA M, TRITOS NA, BB, FLIER JS, MARATOS-FLIER E: Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature (1998) 396(6712):670–674.
   PubMed Web of Science ®Google Scholar
• ••This report describes the phenotype ofpmchl- mice.
   Google Scholar
• SEGAL-LIEBERMAN G, BRADLEY RL, KOKKOTOU E et al.: Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype. Proc. NatL Acad. Sci. USA (2003) 100(17):10085–10090.
   PubMed Web of Science ®Google Scholar
• CHEN Y, HU C, HSU CK et al: Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistance to diet-induced obesity. Endocrinology (2002) 143(7):2469–2477.
   PubMed Web of Science ®Google Scholar
• ••This paper, as well as that of [62], report onthe phenotype of mice lacking the MCH–1R.
   Google Scholar
• MARSH DJ, WEINGARTH DT, NOVI DE et al.: Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Proc. Natl. Acad. Sci. USA (2002) 99(5):3240–3245.
   PubMed Web of Science ®Google Scholar
• ••A study reporting the phenotype ofMCH-1R knockout mice. This study, as well as that of [61], provides support for targeting the MCH-1R for the treatment of obesity.
   Google Scholar
• ASTRAND A, BOHLOOLY-Y M, LARSDOTTER S et al.: Mice lacking the melanin concentrating hormone receptor 1 demonstrate increased heart rate associated with altered autonomic activity. Am. .1 Physiol (2004) (In press).
   Google Scholar
• CARTPENTER AJ, HERTZOG DL: Melanin-concentrating hormone receptor antagonists as potential anti-obesity agents. Expert Opin. Ther. Patents (2002) 12:1639–1646.
   Web of Science ®Google Scholar
• BROWNING A: Recent developments inthe discovery of melanin-concentrating hormone antagonists: novel antiobesity. Expert Opin. The]: Patents (2004) 14:313–325.
   Web of Science ®Google Scholar
• COLLINS CA, KYM PR: Prospects for obesity treatment: MCH receptor antagonists. Carr. Opin. Investig. Drugs (2003) 4(4):386–394.
   PubMedGoogle Scholar
• HUNT H: 12th RSC-SCI Symposium. Cambridge, UK. (2003) IDDB reference 506101.
   Google Scholar
• ADESSI C, SOTO C: Converting a peptide into a drug: strategies to improve stability and bioavailability. Carr: Med. Chem. (2002) 9(9):963–978.
   PubMed Web of Science ®Google Scholar
• CHEN X, WANG W: The use of bioisosteric groups in lead optimization. In: Annual Reports in Medicinal Chemistry (Volume 38). DOHERTY AM (Ed.), Elsevier Academic Press, San Diego, CA, USA (2003):333–346.
   Google Scholar
• TEMPEST PA, NIXEY T, MA Vet al.: Novel potent tetrazole containing melanin concentrating hormone (MCH) receptor antagonists - multi-component reactions lead the way. 227th American Chemical Society Annual Meeting, Anaheim, CA, USA (2004) MEDI298.
   Google Scholar
• TAKEKAWA S, ASAMI A, ISHIHARA Y et al.: T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist. Eui: Pharmacol. (2002) 438(3):129–135.
   PubMed Web of Science ®Google Scholar
• •The first study reporting oral activity of a small molecular weight MCH-1R antagonist using a pharmacodynarnic feeding model.
   Google Scholar
• BOROWSKY B, DURKIN MM, OGOZALEK K et al.: Antidepressant, amdolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat. Med. (2002) 8(8):825–830.
   PubMed Web of Science ®Google Scholar
• ••The first description of an efficacious smallmolecular weight MCH-1R antagonist using a model of rodent obesity. Efficacy in rodent models of anxiety and depression was also reported.
   Google Scholar
• BEDNAREK MA, HRENIUK DL, TAN C et al.: Synthesis and biological evaluation in vitro of selective, high affinity peptide antagonists of human melanin-concentrating hormone action at human melanin-concentrating hormone receptor 1. Biochemistry (2002) 41(20):6383–6390.
   PubMed Web of Science ®Google Scholar
• MILLAN MJ, DEKEYNE A, GOBERT A et al.: Actions of the selective melanin concentrating hormonei receptor antagonist, (±)SNAP-7941, in models of antidepressant and amdolytic activity in rodents. Eucf Neuropsychopharmacol (2003) 13\(Suppl. 4):5268.
   Google Scholar
• BOHLOOLY-Y M, MAHLAPUU M, ANDERSEN H et al.: Osteoporosis in MCHR1-deficient mice. Biochem. Biophys. Res. Commun. (2004) 318:964–969.
   PubMed Web of Science ®Google Scholar